Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Everest Medicines Limited | 6HN | 26. sep 2024 | 2.76 | +2.22 |
Evgen Pharma Plc | 8EV | 26. sep 2024 | 0.00 | 0.00 |
Futura Medical | GYX | 26. sep 2024 | 0.41 | +0.99 |
Galapagos NV - American Depositary Shares | GXEA | 26. sep 2024 | 25.40 | -0.78 |
Genscript Biotech Corporation | G51 | 26. sep 2024 | 1.25 | +2.46 |
GNI Group Ltd. | 3G6 | 26. sep 2024 | 17.90 | +2.29 |
Healios K.K. | 6VX | 26. sep 2024 | 1.37 | -6.16 |
Hemogenyx Pharmaceuticals Plc | 5HU | 26. sep 2024 | 0.02 | +11.11 |
Hybrigenics | 3HB | 26. sep 2024 | 0.01 | +4.23 |
Immupharma Plc | 25I | 26. sep 2024 | 0.01 | 0.00 |
Immutep Limited | YP1B | 26. sep 2024 | 0.19 | +2.11 |
Innovent Biologics Inc | 6IB | 26. sep 2024 | 4.92 | +6.03 |
Inventiva S.A. - American Depository Shares | 6IVA | 26. sep 2024 | 1.62 | -12.90 |
Ixico Plc | PYPB | 26. sep 2024 | 0.11 | +0.90 |
Legend Biotech Corporation - American Depositary Shares | 9LB | 26. sep 2024 | 41.60 | +7.22 |
Medesis Pharma S.A. | 76D | 26. sep 2024 | 0.42 | -1.87 |
Medmira Inc | 47M | 26. sep 2024 | 0.05 | +6.59 |
Memphasys Limited | IG7 | 26. sep 2024 | 0.00 | 0.00 |
Mesoblast Ltd | LWB | 26. sep 2024 | 0.57 | -0.86 |
Nanocarrier Co Ltd | 3NQ | 26. sep 2024 | 1.04 | 0.00 |
NetScientific plc | NTK1 | 26. sep 2024 | 0.58 | +1.74 |
Newron Pharmaceuticals Spa. | NP5 | 26. sep 2024 | 7.87 | -4.26 |
Nuformix plc | 1RT | 26. sep 2024 | 0.00 | 0.00 |
Ocumension Therapeutics | 5DG | 26. sep 2024 | 0.59 | +8.26 |
Oncimmune Holdings plc | OCY | 26. sep 2024 | 0.15 | 0.00 |
Oncoarendi Therapeutics SA | 1B1 | 26. sep 2024 | 3.11 | +0.32 |
Oncotherpapy Science Inc | 30O | 26. sep 2024 | 0.19 | -0.52 |
Open Orphan plc | CRO | 26. sep 2024 | 0.33 | -1.78 |
Opthea Limited | UKJ | 26. sep 2024 | 0.46 | +1.32 |
OptiBiotix Health plc | OB3 | 26. sep 2024 | 0.19 | +1.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.